Chick Embryo Cell Rabies Vaccine Market
Chick Embryo Cell Rabies Vaccine Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2026
Analysis of Chick Embryo Cell Rabies Vaccine Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Introduction
Rabies is a disease caused by Rabies virus. There are so many types of vaccines but Chick embryo cell rabies vaccine is a sterilized vaccine synthesized by growing a fixed strain of rabies virus strain Flury LEP-25. Chick embryo cell rabies vaccine are obtained from primary cultures of chick fibroblasts.
The virus is purified and then concentrated using the zonal centrifugation technique and is inactivated with ß-propiolactone. Purified chick embryo cell vaccine (PCECV) or Chick embryo cell rabies vaccine is a product produced by complex batch-wise manufacturing procedures.
As per WHO (World Health Organization) chick embryo rabies vaccine is 100% efficacious and have helped in saving millions of lives since the 80’s. Chick embryo cell rabies vaccine produced from several different types of cell substrates, such as nerve tissue rabies vaccine are rapidly being replaced by chick embryo cell rabies vaccine rapidly in North America, Asia & Latin America, thus fueling the growth of chick embryo cell rabies vaccine. Although chick embryo cell rabies vaccine are expensive, they are considered highly efficacious.
As per a study published by NCBI in 2014, globally, 55,000 people dies from rabies every year out of which, 56% dies in Asia and 44% die in Africa. Approximately 3.3 billion people are in the risk of human infection mainly in Asia and Africa. The existing patient pool and the risk of being infected with rabies are the major factors driving the chick embryo cell rabies vaccine market.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Global Chick Embryo Cell Rabies Vaccine Market: Drivers and Restraints
Rise in the number of stray animals in developing countries is expected to be the major factor, diving the growth of the Global Chick embryo cell rabies vaccine market over the forecast period.
Other factors which are expected to provide fuel the growth of Global Chick embryo cell rabies vaccine market in the next few decades include, search for novel routes of vaccine administration, increase prevalence of animal bites, awareness among population.
However, less supply of Chick embryo cell rabies vaccine in remote areas, strict government rules regarding the safety and efficacy of the Chick embryo cell rabies vaccine are the factors which may hinder the growth of Global Chick embryo cell rabies vaccine market during the forecast period.
Global Chick Embryo Cell Rabies Vaccine Market: Overview
The global market for Chick Embryo Cell Rabies Vaccine is expected to generate significant revenue with a huge growth over the forecast due to high demand of Chick Embryo Cell Rabies Vaccine for the treatment infection caused by Rabies virus. Based on application, Pre-exposure prophylaxis of Chick Embryo Cell Rabies Vaccine is preferred due to less cost compared to Chick Embryo Cell Rabies Vaccine for Post-exposure prophylaxis.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Global Chick Embryo Cell Rabies Vaccine Market: Regional Outlook
Geographically, the global Chick Embryo Cell Rabies Vaccine market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa.
North America is anticipated to remain as dominant market player in global Chick Embryo Cell Rabies Vaccine market with largest share as the government arranged programs to eradicate Rabies from country compared to other regions.
Other factors such as pet adoption, awareness among population, rise in healthcare expenditure, animal vaccination increase the growth in this region. Europe is expected to hold the second largest revenue share in the global Chick Embryo Cell Rabies Vaccine market throughout the forecast period owing to the rise in the adoption of pets.
However rapid growth is expected from Asia-Pacific, due to increase in the investment for healthcare and research sector, attracting the manufacturers with a lots of possibilities to explore their business of Chick Embryo Cell Rabies Vaccine.
Global Chick Embryo Cell Rabies Vaccine Market: Key Players
Chick Embryo Cell Rabies Vaccine manufacturers focus on improved precision with even better accuracy of targeting the radiation. The Chick Embryo Cell Rabies Vaccine market is highly fragmented owing to presence of a large number of domestic manufacturers.
Examples of some of the key players operating in the Chick Embryo Cell Rabies Vaccine market are Major manufacturers for Chick Embryo Cell Rabies Vaccine include: GlaxoSmithKline Inc, Novartis, Sanofi Pasteur and others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
- Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- APEJ (Greater China, India, S. Korea, ASEAN Countries and Rest of APEJ)
- Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Global Chick Embryo Cell Rabies Vaccine Market: Segmentation
Tentatively, the Global chick embryo rabies vaccine market can be segmented on the basis of application, distribution and end user.
On the basis of Application, Chick Embryo Cell Rabies Vaccine Market can be segmented as:
- Pre-exposure prophylaxis (intra-dermal)
- Post-exposure prophylaxis (intra-muscular)
On the basis of distribution, Chick Embryo Cell Rabies Vaccine Market can be segmented as:
- Retail pharmacies
- Hospital pharmacies
- E-commerce
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Application 6.2. Distribution 7. Global Market Analysis and Forecast, By Application 7.1. Pre-exposure prophylaxis (intra-dermal) 7.2. Post-exposure prophylaxis (intra-muscular) 8. Global Market Analysis and Forecast, By Distribution 8.1. Retail pharmacies 8.2. Hospital pharmacies 8.3. E-commerce 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. Asia Pacific 9.6. East Asia 9.7. MEA 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. MEA Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Application and Distribution for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. GlaxoSmithKline Inc 19.2. Novartis 19.3. Sanofi Pasteur
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Application
Table 3: Global Market US$ Mn Forecast by Distribution
Table 4: North America Market US$ Mn Forecast by Country
Table 5: North America Market US$ Mn Forecast by Application
Table 6: North America Market US$ Mn Forecast by Distribution
Table 7: Latin America Market US$ Mn Forecast by Country
Table 8: Latin America Market US$ Mn Forecast by Application
Table 9: Latin America Market US$ Mn Forecast by Distribution
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Application
Table 12: Western Europe Market US$ Mn Forecast by Distribution
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Application
Table 15: Eastern Europe Market US$ Mn Forecast by Distribution
Table 16: Asia Pacific Market US$ Mn Forecast by Country
Table 17: Asia Pacific Market US$ Mn Forecast by Application
Table 18: Asia Pacific Market US$ Mn Forecast by Distribution
Table 19: East Asia Market US$ Mn Forecast by Country
Table 20: East Asia Market US$ Mn Forecast by Application
Table 21: East Asia Market US$ Mn Forecast by Distribution
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Application
Table 24: MEA Market US$ Mn Forecast by Distribution
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 17: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 18: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 20: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Chick Embryo Cell Rabies Vaccine Market